Dr. Schmaier is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2103 Cornell Road, WRB2-130
WRB2-130
Cleveland, OH 44106Phone+1 216-368-0796Fax+1 216-368-1166
Summary
- Dr. Alvin H. Schmaier, M.D. is the Robert W. Kellermeyer Professor of Hematology and Oncology in Medicine and Pathology at Case Western Reserve University and University Hospitals Cleveland Medical Center, Cleveland OH. Previously he was a full tenured professor at Temple University and the University of Michigan. He is an elected member of the American Society of Clinical Investigation (1990), the Peripathetic Club (1991), and the Association of American Physicians (1998). He frequently serves on NIH study sections. He is an active member of the American Society of Hematology and the International Society of Thrombosis and Haemostasis. He has a NIH funded laboratory since 1979 and has 230 publications listed on My NCBI PubMed. His research has focused on the vascular biology of factor XII and the kallikrein/kinin system and hemostasis and thrombosis. He is hematologist with a practice that is exclusively hemostasis, thrombosis, and hemophilia.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1977 - 1980
Temple University HospitalResidency, Internal Medicine, 1974 - 1977
Virginia Commonwealth University School of MedicineClass of 1974
Certifications & Licensure
OH State Medical License 2006 - 2026
MI State Medical License 1991 - 2007
PA State Medical License 1975 - 1992- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014, 2022
- Elected Member Association of American Physicians, 1990
- Elected Member American Society of Clinical Investigation
Clinical Trials
- Initial Treatment of Patients With Immune Thrombocytopenic Purpura Start of enrollment: 2010 Jan 01
- Prospective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life Practice Start of enrollment: 2016 Dec 14
Publications & Presentations
PubMed
- The angiotensin II/type 1 angiotensin II receptor pathway is implicated in the dysfunction of albumin endocytosis in renal proximal tubule epithelial cells induced by ...Liz G Afonso, Rodrigo P Silva-Aguiar, Douglas E Teixeira, Sarah A S Alves, Alvin H Schmaier
Biochimica Et Biophysica Acta. General Subjects. 2024-10-01 - The enigma of factor XII surface binding.Sadiq Silbak, Alvin H Schmaier
Journal of Thrombosis and Haemostasis. 2024-09-01 - 1 citationsToll like receptor 4 mediates the inhibitory effect of SARS-CoV-2 spike protein on proximal tubule albumin endocytosis.Rodrigo P Silva-Aguiar, Douglas E Teixeira, Diogo B Peruchetti, Rodrigo A S Peres, Sarah A S Alves
Biochimica Et Biophysica Acta. Molecular Basis of Disease. 2024-06-01
Journal Articles
- Assessment of Whole Blood Coagulation with a Microfluidic Dielectric SensorAlvin H Schmaier, Journal of Thrombosis and Haemostasis
Abstracts/Posters
- Outcomes after Treatment with Upfront Cyclophosphamide or Rituximab for Initial Acquired Thrombotic Thrombocytopenic PurpuraAlvin H. Schmaier, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Mice Deficient in ¤2-Glycoprotein I Have a Delayed Time to ThrombosisAlvin H. Schmaier, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Special Symposium on the Basic Science of Hemostasis and Thrombosis60th American Society of Hematology Annual Meeting - 12/3/2018
- Vascular Biology Components of Hemostasis60th American Society of Hematology Annual Meeting - 12/2/2018
- Neutrophil KLF2 Regulates Arterial and Venous Thrombosis2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Grant Support
- Prolylcarboxypeptidase Is A Risk Factor For Cardiovascular DiseaseNational Heart, Lung, And Blood Institute2012
- Regulation Of Kinin Delivery On HuvecNational Heart, Lung, And Blood Institute2006–2012
- Thrombostatin-A Thrombin Receptor InhibitorNational Heart, Lung, And Blood Institute2005–2006
- Regulation Of Kinin Delivery On HuvecNational Heart, Lung, And Blood Institute1996–2005
- Plasma Protein Phenotyping Of Prothrombotic MiceNational Heart, Lung, And Blood Institute2000–2003
- Thrombostatin In The Folts Model For Coronary ThrombosisNational Heart, Lung, And Blood Institute2001
- Core--Mouse Coagulaltion LaboratoryNational Heart, Lung, And Blood Institute1997–2001
- Thrombostatin--A Selective AntithrombinNational Heart, Lung, And Blood Institute1997–1999
- Platelet High Molecular Weight KininogenNational Heart, Lung, And Blood Institute1991–1994
- Interaction Of High MR Kininogen And PlateletsNational Heart, Lung, And Blood Institute1991
- Interaction Of High MR Kininogen And PlateletsNational Heart, Lung, And Blood Institute1987–1991
- Platelet High Molecular Weight KininogenNational Heart, Lung, And Blood Institute1986–1991
- Interaction Of Platelets With Early Blood CoagulationNational Heart, Lung, And Blood Institute1985
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
